Brown Brothers Harriman & CO Medtronic PLC Transaction History

Brown Brothers Harriman & CO

$14 Billion
Q3 2024

A detailed history of Brown Brothers Harriman & CO transactions in Medtronic PLC stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 170,052 shares of MDT stock, worth $13.8 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

170,052

Previous 200,971 15.38%

Holding current value

$13.8 Million

Previous $15.8 Million 3.22%

% of portfolio

0.11%

Previous 0.12%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$76.84 - $91.03 $2.38 Million - $2.81 Million	-30,919 Reduced 15.38%	170,052 $15.3 Million
Q2 2024 Aug 09, 2024	SELL	$78.71 - $87.02 $2.95 Million - $3.26 Million	-37,517 Reduced 15.73%	200,971 $15.8 Million
Q1 2024 May 10, 2024	SELL	$82.84 - $88.09 $1.29 Million - $1.37 Million	-15,516 Reduced 6.11%	238,488 $20.8 Million
Q4 2023 Feb 12, 2024	BUY	$69.43 - $83.43 $1.69 Million - $2.03 Million	24,292 Added 10.57%	254,004 $20.9 Million
Q3 2023 Nov 13, 2023	BUY	$78.22 - $90.4 $2.82 Million - $3.26 Million	36,092 Added 18.64%	229,712 $18 Million
Q2 2023 Aug 07, 2023	BUY	$79.47 - $91.38 $13.5 Million - $15.6 Million	170,498 Added 737.38%	193,620 $17.1 Million
Q1 2023 May 11, 2023	SELL	$76.72 - $87.58 $87,460 - $99,841	-1,140 Reduced 4.7%	23,122 $1.86 Million
Q4 2022 Feb 09, 2023	SELL	$76.18 - $87.74 $125,849 - $144,946	-1,652 Reduced 6.37%	24,262 $1.89 Million
Q3 2022 Nov 10, 2022	BUY	$80.75 - $95.31 $111,838 - $132,004	1,385 Added 5.65%	25,914 $2.09 Million
Q2 2022 Aug 11, 2022	SELL	$87.4 - $113.09 $506,220 - $655,017	-5,792 Reduced 19.1%	24,529 $2.2 Million
Q1 2022 May 13, 2022	SELL	$100.58 - $112.38 $2.49 Million - $2.78 Million	-24,712 Reduced 44.9%	30,321 $3.36 Million
Q4 2021 Feb 14, 2022	BUY	$99.53 - $127.75 $2.15 Million - $2.76 Million	21,591 Added 64.56%	55,033 $5.69 Million
Q3 2021 Nov 15, 2021	SELL	$122.75 - $135.17 $174,182 - $191,806	-1,419 Reduced 4.07%	33,442 $4.19 Million
Q2 2021 Aug 13, 2021	BUY	$118.19 - $131.5 $158,965 - $176,867	1,345 Added 4.01%	34,861 $4.33 Million
Q1 2021 May 13, 2021	SELL	$111.18 - $119.74 $165,991 - $178,771	-1,493 Reduced 4.26%	33,516 $3.96 Million
Q4 2020 Feb 16, 2021	SELL	$100.57 - $117.14 $131,444 - $153,101	-1,307 Reduced 3.6%	35,009 $4.1 Million
Q3 2020 Nov 16, 2020	SELL	$90.13 - $108.78 $250,651 - $302,517	-2,781 Reduced 7.11%	36,316 $3.77 Million
Q2 2020 Aug 13, 2020	BUY	$84.11 - $103.33 $835,296 - $1.03 Million	9,931 Added 34.05%	39,097 $3.59 Million
Q1 2020 May 15, 2020	SELL	$72.92 - $121.3 $250,990 - $417,514	-3,442 Reduced 10.56%	29,166 $2.63 Million
Q4 2019 Feb 14, 2020	SELL	$104.49 - $114.54 $47,960 - $52,573	-459 Reduced 1.39%	32,608 $3.7 Million
Q3 2019 Nov 14, 2019	BUY	$98.02 - $111.18 $3,822 - $4,336	39 Added 0.12%	33,067 $3.59 Million
Q2 2019 Aug 14, 2019	BUY	$84.15 - $99.38 $57,811 - $68,274	687 Added 2.12%	33,028 $3.22 Million
Q1 2019 May 15, 2019	SELL	$82.45 - $93.79 $637,915 - $725,653	-7,737 Reduced 19.3%	32,341 $2.95 Million
Q4 2018 Feb 14, 2019	BUY	$85.8 - $99.49 $851,736 - $987,637	9,927 Added 32.92%	40,078 $3.65 Million
Q3 2018 Nov 14, 2018	BUY	$85.91 - $99.17 $288,571 - $333,112	3,359 Added 12.54%	30,151 $2.97 Million
Q2 2018 Aug 14, 2018	SELL	$77.48 - $87.83 $137,681 - $156,073	-1,777 Reduced 6.22%	26,792 $2.29 Million
Q1 2018 May 14, 2018	SELL	$76.55 - $87.26 $221,306 - $252,268	-2,891 Reduced 9.19%	28,569 $2.29 Million
Q4 2017 Feb 14, 2018	BUY	$76.93 - $83.5 $52,389 - $56,863	681 Added 2.21%	31,460 $2.54 Million
Q3 2017 Nov 14, 2017	BUY	$77.71 - $84.6 $91,309 - $99,405	1,175 Added 3.97%	30,779 $2.39 Million
Q2 2017 Aug 14, 2017	BUY	N/A	29,604	29,604 $2.63 Million

Others Institutions Holding MDT

# of Institutions

2,288

Shares Held

1.02B

Call Options Held

8.05M

Put Options Held

7.19M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $108B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

News

Stay updated on Brown Brothers Harriman & CO with notifications on news.

Account

Brown Brothers Harriman & CO Medtronic PLC Transaction History